Moderna expects US CDC to view its RSV vaccine as equal to rival shots, shares jump
By Patrick Wingrove and Leroy Leo London: Moderna said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC) advisers to recommend the company's respiratory syncytial virus (RSV) vaccine be considered equal to rival shots launched …